Log in
Enquire now
‌

Neovacs

Neovacs is a cytokine Immunotherapy.

OverviewStructured DataIssuesContributors

Contents

neovacs.fr
neovacs.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Biopharmaceutical
Biopharmaceutical
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Immunotherapy
Immunotherapy
Investors
Novartis Venture Fund
Novartis Venture Fund
Truffle Capital
Truffle Capital
Total Funding Amount (USD)
17,902,300
Latest Funding Round Date
July 17, 2007
Patents Assigned (Count)
10
Country
France
France
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Neovacs

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.